Previous 10 | Next 10 |
home / stock / nriff / nriff news
Nuvo Pharmaceuticals™ Announces 2019 Third Quarter Results Canada NewsWire MISSISSAUGA, ON, Oct. 31, 2019 · Third Quarter Adjusted Total Revenue - $18.9 million and $55.1 million year-to-date · · Third Quarter Adjusted EBITD...
Nuvo Pharmaceuticals™ Announces Third Quarter 2019 Results Release Date and Conference Call Details Canada NewsWire MISSISSAUGA, ON, Oct. 17, 2019 MISSISSAUGA, ON , Oct. 17, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Cana...
Nuvo Pharmaceuticals™ Update to Nuvo's Presentation Time at H.C. Wainwright Global Investment Conference Canada NewsWire MISSISSAUGA, ON, Sept. 9, 2019 - Tuesday, September 10, 2019 – 4:15 p.m. ET - MISSISSAUGA, ON , Sept. 9, 2019 /CNW/ - Nuvo...
- Tuesday, September 10, 2019 – 4:15 p.m. ET - MISSISSAUGA, ON , Sept. 9, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial pr...
Nuvo Pharmaceuticals™ to Present at H.C. Wainwright Global Investment Conference Canada NewsWire MISSISSAUGA, ON, Sept. 4, 2019 MISSISSAUGA, ON , Sept. 4, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healt...
MISSISSAUGA, ON , Sept. 4, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced that Jesse Ledger , Nuvo's President & C...
Nuvo Pharmaceuticals Inc. (NRIFF) Q2 2019 Earnings Conference Call August 14, 2019 08:30 AM ET Company Participants Jesse Ledger - President & Chief Executive Officer Mary-Jane Burkett - Vice President & Chief Financial Officer Tina Loucaides - Vice President, Secretary &...
• Second Quarter Adjusted Total Revenue - $19.1 million • • Second Quarter Adjusted EBITDA - $5.7 million • • Second Quarter Gross Profit - $9.6 million • - Nuvo to Host Conference Call/Audio Webcast August 14th at 8:...
MISSISSAUGA, ON , July 31, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it intends to release its second quarter 2019 ...
The U.S. Court of Appeals has denied a rehearing request from Nuvo Pharmaceuticals ( OTCQX:NRIFF ) seeking to reverse its decision invalidating two U.S. patents covering anti-inflammatory med VIMOVO (naproxen/esomeprazole magnesium). More news on: Nuvo Pharmaceuticals Inc., Healthcare st...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Research Inc Company Name:
NRIFF Stock Symbol:
OTCMKTS Market:
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...